BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2940136)

  • 1. Late-onset hexosaminidase A and hexosaminidase A and B deficiency: family study and review.
    Adams C; Green S
    Dev Med Child Neurol; 1986 Apr; 28(2):236-43. PubMed ID: 2940136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases].
    Beĭer EM; Vidershaĭn GIa; Venert M
    Biull Eksp Biol Med; 1984 Jan; 97(1):83-6. PubMed ID: 6229294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segregation of Tay-Sachs and Sandhoff alleles in a non-Jewish family.
    Lane AB; Young E; Jenkins T
    Am J Hum Genet; 1980 Nov; 32(6):920-6. PubMed ID: 7446530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity of the hexosaminidase deficiency diseases.
    Johnson WG
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():215-37. PubMed ID: 6337393
    [No Abstract]   [Full Text] [Related]  

  • 5. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
    Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
    Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
    Gort L; de Olano N; Macías-Vidal J; Coll MA;
    Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.
    Mahuran DJ
    Biochim Biophys Acta; 1991 Feb; 1096(2):87-94. PubMed ID: 1825792
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R; Rangaswamy GR; Shetty KT
    Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
    Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
    Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
    Chamoles NA; Blanco M; Gaggioli D; Casentini C
    Clin Chim Acta; 2002 Apr; 318(1-2):133-7. PubMed ID: 11880123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients.
    Tropak MB; Reid SP; Guiral M; Withers SG; Mahuran D
    J Biol Chem; 2004 Apr; 279(14):13478-87. PubMed ID: 14724290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.
    Argov Z; Navon R
    Ann Neurol; 1984 Jul; 16(1):14-20. PubMed ID: 6235771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-N-acetyl-hexosaminidase--the enzyme of Tay-Sachs and Sandhoff diseases].
    Zwierz K; Juszkiewicz J; Arciuch L; Gindzieński A
    Postepy Biochem; 1992; 38(3):127-32. PubMed ID: 1461844
    [No Abstract]   [Full Text] [Related]  

  • 17. GM2 gangliosidosis with a motor neuron disease phenotype: clinical heterogeneity of hexosaminidase deficiency disease.
    Federico A
    Adv Exp Med Biol; 1987; 209():19-23. PubMed ID: 2953177
    [No Abstract]   [Full Text] [Related]  

  • 18. Nomenclature of GM2-gangliosidoses.
    Nørby S
    Clin Genet; 1980 May; 17(5):320-2. PubMed ID: 7192191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two abnormalities of hexosaminidase A in clinically normal individuals.
    Grebner EE; Mansfield DA; Raghavan SS; Kolodny EH; d'Azzo A; Neufeld EF; Jackson LG
    Am J Hum Genet; 1986 Apr; 38(4):505-14. PubMed ID: 2939713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
    Buchalter MS; Wannmacher CM; Wajner M
    J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.